Validation of a clinical assay of multi-locus DNA methylation for prognosis of newly diagnosed AML.
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Courtney D
CD
Dinardo
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Marlise R
MR
Luskin
Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Martin
M
Carroll
Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Catherine
C
Smith
Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Jenna
J
Harrison
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Sherry
S
Pierce
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Steve
S
Kornblau
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Marina
M
Konopleva
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Tapan
T
Kadia
Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, Texas.
Hagop
H
Kantarjian
Department of Pathology & Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Gerald B
GB
Wertheim
Department of Pathology & Laboratory Medicine, Weill Cornell Medical College, New York, New York.
Stephen R
SR
Master
D014408:Biomarkers, Tumor; D019175:DNA Methylation; D057890:Epigenomics / Q000379:methods* / Q000592:standards; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000175:diagnosis* / Q000235:genetics* / Q000401:mortality / Q000628:therapy; D011379:Prognosis; D040641:Quantitative Trait Loci; D015203:Reproducibility of Results
D014408:Biomarkers, Tumor